vitamin C - Ontology Report - Rat Genome Database

NCBI chr 6:79,589,695...79,649,646
Ensembl chr 6:79,589,045...79,649,644

BCL2L1

BCL2 like 1

multiple interactions

[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of BCL2L1 mRNA

NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694

CASP3

caspase 3

multiple interactions

[Troglitazone co-treated with beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CASP3 mRNA

NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213

CEBPA

CCAAT enhancer binding protein alpha

multiple interactions

[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CEBPA mRNA]

NCBI chr 6:43,083,200...43,085,884
Ensembl chr 6:43,083,207...43,085,836

COL1A1

collagen type I alpha 1 chain

multiple interactions

NCBI chr12:26,379,087...26,397,180
Ensembl chr12:26,379,090...26,397,004

CTNNB1

catenin beta 1

multiple interactions

2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA]; [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of CTNNB1 mRNA]

NCBI chr13:25,163,550...25,208,314
Ensembl chr13:25,164,277...25,208,311

FABP4

fatty acid binding protein 4

multiple interactions

2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]; [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]

NCBI chr 4:55,096,400...55,101,209
Ensembl chr 4:55,096,404...55,101,896

IGF1

insulin like growth factor 1

multiple interactions

[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1 mRNA]

NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033

IGF1R

insulin like growth factor 1 receptor

multiple interactions

[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of IGF1R mRNA]

NCBI chr 1:137,383,623...137,691,038
Ensembl chr 1:137,387,825...137,691,058

PPARG

peroxisome proliferator activated receptor gamma

multiple interactions

2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]; [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of PPARG mRNA]

NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944

RUNX2

RUNX family transcription factor 2

multiple interactions

NCBI chr 7:40,106,581...40,353,304
Ensembl chr 7:40,106,532...40,460,687

SPP1

secreted phosphoprotein 1

multiple interactions

2,2-bis(4-glycidyloxyphenyl)propane promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA]; [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA; Troglitazone promotes the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] results in increased expression of SPP1 mRNA]